Statistics for Clover Health Investments, (id:8080 CLOV)
Valuation metrics
Market cap
1,62B
Enterprise value
1,27B
Trailing P/E (ttm)
-8,27
Forward P/E
-23,07
PEG ratio
-23,07
Price/Sales (ttm)
3,00
Price/Book (mrq)
4,72
Enterprise Value/Revenue
3,00
Enterprise Value/EBITDA
-16,43
Overview
Shares outstanding
412,08M
Float
393,99M
Shares short
15,28M
% Held by insiders
5,00%
% Held by institutions
3,00%
Average volume (10 days)
4,71M
Average volume (90 days)
Price summary
52-Week low
3,00
52-Week high
4,71
52-Week change
73,74%
Beta
2,04
50-Day moving average
3,61
200-Day moving average
2,11
Dividends and splits
Forward annual dividend rate
Forward annual dividend yield
Trailing annual dividend rate
0,00%
Trailing annual dividend yield
0,00
5-Year annual dividend yield
Payout ratio
0,00
Dividend date
Ex-dividend date
Last split factor
2:1
Last split date
Financials
Fiscal yearFiscal year ends
December 31, 2023
Most recent quarter (mrq)
September 30, 2024
Profitability
Profit margin
-4,32%
Operating margin
-2,82%
Operational effectiveness
Return on assets
-5,66%
Return on equity
-28,90%
Income statement
Revenue (ttm)
4,34
Revenue per share (ttm)
4,34
Quarterly revenue growth (yoy)
5,00
Gross profit (ttm)
257,33M
EBITDA
-77.085.000,00
Net income to common (ttm)
-95.943.000,00
Diluted EPS (ttm)
3,00
Quarterly earnings growth (yoy)
8,16%
Balance sheet
Total cash (mrq)
333,05M
Total cash per share (mrq)
3,00
Total debt (mrq)
3,67M
Total Debt/Equity (mrq)
1,07
Current ratio (mrq)
154,70%
Book value per share (mrq)
3,00
Cash flow
Cash flow statement
-108.617.000,00
Levered free cash flow (LFCF)
103,22M